Ask AI
EGFRm NSCLC Brain Metastases

CE / CME

Management of a Patient With EGFR-Mutated NSCLC and Brain Metastases

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Pharmacists: 0.50 contact hour (0.05 CEUs)

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: May 04, 2026

Expiration: November 03, 2026

Activity

Progress
1 2
Course Completed

Case Follow-up
She receives stereotactic radiosurgery to the dominant left temporal lesion and completes a dexamethasone taper with resolution of her headache. Resistance evaluation does not reveal a new actionable alteration, so the team now turns to the next systemic treatment choice.

Which of the following systemic treatment options would you recommend as the next step in her care now?